Singapore markets closed
Straits Times Index
3,090.31 +17.32 (+0.56%) Nikkei
33,431.51 -55.38 (-0.17%) Hang Seng
16,830.30 -212.58 (-1.25%) FTSE 100
7,529.35 +75.60 (+1.01%) Bitcoin USD
38,774.12 +680.66 (+1.79%) CMC Crypto 200
802.76 +11.20 (+1.41%)
ABBV Jan 2024 95.000 call
OPR - OPR Delayed Price. Currency in USD
Add to watchlist
At close: 09:29AM EST
| Previous close | 54.00 |
| Open | 54.00 |
| Bid | 54.00 |
| Ask | 54.55 |
| Strike | 95.00 |
| Expiry date | 2024-01-19 |
| Day's range | 54.00 - 54.00 |
| Contract range | N/A |
| Volume | |
| Open interest | 24 |
Insider MonkeyCollPlant Biotechnologies Ltd. (NASDAQ:CLGN) Q3 2023 Earnings Call Transcript
CollPlant Biotechnologies Ltd. (NASDAQ:CLGN) Q3 2023 Earnings Call Transcript November 29, 2023 CollPlant Biotechnologies Ltd. misses on earnings expectations. Reported EPS is $-0.38 EPS, expectations were $-0.13. Operator: Greetings. And welcome to the CollPlant Biotechnologies Third Quarter 2023 Earnings Conference Call. [Operator Instructions] As a reminder, this conference is being recorded. I would now like […]
ZacksPharma Stock Roundup: ABBV to Buy Immunogen, NVS Ups Mid-Term Sales View & More
AbbVie (ABBV) offers to acquire cancer biotech Immunogen for $10.1 billion. Novartis (NVS) raises its mid-term sales growth outlook by 1%.
ZacksAbbVie (ABBV) to Acquire ImmunoGen (IMGN) for $10.1 Billion
AbbVie (ABBV) offers to buy ImmunoGen (IMGN) for approximately $10.1 billion, which will diversify its oncology pipeline across solid tumors and hematologic malignancies.
© 2023 Yahoo. All rights reserved.